We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Western Europe,Australasia
Monthly Production Capacity: 1000000kg
Packaging Information: 500g/bag , 1kg/bag, 10kg/drum , 20kg/drum or customized
Delivery Lead Time: 1
Sample Provided: yes
Payment Terms: TT
The estrogenic effect of soybean isoflavones affects hormone secretion, metabolic biological activity, protein synthesis and growth factor activity. It is a natural cancer chemical preventive agent. Delaying female aging, improving menopausal symptoms, osteoporosis, elevated blood lipid, breast cancer, prostate cancer, heart disease, osteoporosis, cardiovascular disease, etc. Soybean isoflavones can improve the symptoms of myocardial ischemia, dilate blood vessels, inhibit platelet aggregation, reduce blood cholesterol and triglyceride content, and have anti-arrhythmic effect.
Cyclodextrin is widely used as a drug carrier, which can improve the water solubility and stability of drugs. Hydroxypropyl-beta-cyclodextrin (HP-beta-CD) is one of the most widely used cyclodextrin derivatives. The synthetic experiments showed that the water solubility and stability of soybean isoflavones were significantly improved after inclusion with cyclodextrin.